Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $68.2 million versus the consensus estimate of $69.9 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.